International Flavors & Fragrances Inc.

International Flavors & Fragrances Inc. (IFF) Market Cap

International Flavors & Fragrances Inc. has a market capitalization of $20.23B.

Price: $79.22

-0.26 (-0.33%)

Market Cap: 20.23B

NYSE · time unavailable

CEO: Jon Erik Fyrwald

Sector: Basic Materials

Industry: Chemicals - Specialty

IPO Date: 1974-12-17

Website: https://www.iff.com

International Flavors & Fragrances Inc. (IFF) - Company Information

Market Cap: 20.23B|Sector: Basic Materials

Company Profile

International Flavors & Fragrances Inc. (IFF), through its various subsidiaries, operates as a global developer and purveyor of active cosmetic and natural health ingredients. These vital components are incorporated into a wide array of consumer goods distributed across significant markets such as Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. The company's activities are organized into four principal divisions: 1. Nourish: This segment focuses on natural and plant-derived specialty food ingredients, offering items like flavor compounds, savory solutions, and inclusions. It also provides natural food protection solutions, including antioxidants and anti-microbials, for use in beverages, confectionery, and dairy items. 2. Scent: The Scent division creates fragrance compounds, encompassing luxurious fine fragrances (perfumes and colognes) and everyday consumer fragrances. It further supplies essential fragrance ingredients, both synthetic and natural, which are blended to formulate new scents. Additionally, this segment delivers cosmetic active ingredients, such as functional compounds, botanicals, and advanced delivery systems, designed to enhance customers' cosmetic and personal care product lines. 3. Health & Biosciences: This segment is dedicated to the research, development, and production of enzymes, food cultures, probiotics, and other specialized biological ingredients. 4. Pharma Solutions: This division is responsible for manufacturing and distributing cellulosic and seaweed-derived pharmaceutical excipients. IFF's diverse customer base primarily consists of manufacturers in sectors including perfumery, cosmetics, hair and personal care, soaps and detergents, cleaning products, dairy, meat and processed foods, beverages, snacks and savory items, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional foods, and producers of pharmaceutical excipients and oral care products. Established in 1833, International Flavors & Fragrances Inc. is headquartered in New York, New York.

Analyst Sentiment

79%
Strong Buy

From 21 Active Polls

1Y Forecast: $89.57

▲ +13.1% Potential Upside

Consensus Target Metrics

Low Bound

$75

Median

$90

High Bound

$95

Average

$90

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$89.57
▲ +13.06% Upside
Low Target
$75.00
-5% Risk
Median Target
$90.00
14% Mid
High Target
$95.00
20% Max
Consensus
Buy
24 / 33 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)20,22518,57317,25215,75418,82919,86821,64526,86223,751
Enterprise Value ($M)25,48023,82823,31322,37124,86329,16630,79736,08733,166
Price to Earnings Ratio (P/E)24.1527.48240.6896.167.69-4.88-117.43114.0534.75
Price/Earnings-to-Growth Ratio (PEG)4.68-1.8891.53
Price to Sales Ratio (P/S)1.876.786.665.856.816.997.819.188.22
Price to Book Ratio (P/B)1.441.321.221.111.311.511.561.821.67
Price to Free Cash Flow Ratio (P/FCF)50.82201.88132.71525.14128.96-382.08104.06104.12153.23
Enterprise Value to Sales (EV/Sales)8.699.008.309.0010.2611.1112.3411.48
Enterprise Value to EBITDA (EV/EBITDA)12.7747.7575.6963.7429.70-42.45156.3386.5465.29
Debt to Equity Ratio2.630.410.470.510.480.750.690.660.71

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

```html

📘 INTERNATIONAL FLAVORS & FRAGRANCES (IFF) — Investment Overview

🧩 Business Model Overview

IFF develops and manufactures branded and proprietary ingredients used by large consumer manufacturers in food, beverage, home, personal care, and fragrance end markets. The operating model is application-led: teams co-develop formulations with customers, qualify products through regulatory and performance testing, and then supply through a global manufacturing footprint.

The value chain starts with raw material sourcing (including commodity and specialty inputs), conversion into finished flavor/fragrance systems, and ongoing technical support to ensure performance and compliance in customers’ products. Customer “stickiness” is supported by qualification cycles, technical know-how, and the effort involved in re-formulating and re-approving alternatives.

💰 Revenue Streams & Monetisation Model

Revenue is primarily generated through the sale of flavor and fragrance ingredients and related solutions. Monetisation is driven by a combination of:

  • Ingredient sales with repeat demand: Many applications persist because they are embedded in product lines and require periodic replenishment.
  • Technical and application development: Custom work and co-creation often leads to longer qualification windows and follow-on orders.
  • Portfolio and mix management: Higher-value solutions (including specialized flavor systems and performance fragrance ingredients) typically command better gross margin profiles.

Margin drivers tend to include (1) mix shift toward specialty and application-specific products, (2) operational leverage from scale in manufacturing and shared platforms, (3) disciplined cost management, and (4) the extent to which pricing mechanisms can offset commodity and energy volatility. IFF’s model typically converts pricing and mix durability into relatively resilient profitability compared with more commoditized chemical intermediates.

🧠 Competitive Advantages & Market Positioning

IFF competes in a global, technical ingredients market characterized by high switching frictions and deep customer integration. The primary moat is customer qualification and switching costs, reinforced by intangible assets (formulation know-how and proprietary ingredient systems).

  • Switching costs (hard to replace once qualified): Customers invest in sensory/performance validation, regulatory documentation, stability testing, and supplier approvals. Changes can require re-qualification, creating friction against supplier substitution.
  • Intangible assets: Extensive application knowledge, proprietary molecules/ingredient systems, and platform capabilities in formulation and supply reliability.
  • Customer co-development: Technical teams operating at the formulation level strengthen relationships and reduce the probability of “spec-only” purchasing.

Competitive benchmarking:

  • Givaudan — strong in fragrances and flavors with a broad technical platform; competes heavily on product performance and application expertise.
  • Firmenich / DSM-Firmenich — emphasizes innovation in fragrances and taste solutions and a platform approach to ingredient systems.
  • Symrise — strong across fragrance and flavor categories with emphasis on scent and taste performance and customer collaboration.

IFF’s differentiation relative to these peers generally rests on its breadth across taste, fragrance, and selected nutrition/health-related solutions, supported by scale and an ability to provide end-to-end application support across multiple end markets. Rather than competing as a pure commodity ingredient provider, IFF competes as a technical partner integrated into customer formulation pipelines.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, growth prospects for IFF are tied to both volume/demand expansion and the mix shift toward higher-value and more differentiated applications:

  • Premiumization and product innovation in consumer categories: Growth in value-added food and personal care applications supports demand for specialized flavor and fragrance systems.
  • Regulatory and reformulation cycles: Compliance-driven changes (taste, labeling, ingredient restrictions) can favor suppliers with strong technical/regulatory capabilities and qualification track records.
  • Health and nutrition-led formulations: Tailwinds from consumer preference shifts can increase demand for tailored taste systems and functional ingredient solutions.
  • Fragrance development for personal care: Persistent need for differentiation, scent profiling, and portfolio refresh cycles supports ongoing ingredient replacement and new SKU introductions.
  • Biobased and sustainability-driven sourcing: Customers increasingly seek responsibly sourced inputs and performance-equivalent alternatives, supporting providers with manufacturing flexibility and sustainability credentials.

Importantly, the TAM is expanded not only through incremental consumer demand but also through the migration from “simple” formulations toward more complex ingredient systems where technical services and IP drive purchase decisions.

⚠ Risk Factors to Monitor

  • Input cost and supply volatility: Commodity and specialty input price swings can pressure margins if pass-through mechanisms lag or are incomplete.
  • Customer concentration and buying power: Large consumer goods manufacturers can exert pricing pressure, require margin participation, or consolidate supplier panels.
  • Regulatory complexity: Food safety and fragrance regulations demand ongoing compliance investment and can constrain certain ingredients or require reformulation.
  • Technology and substitution risk: Innovations in alternatives (including synthetic biology pathways, other scent/taste modalities, or new carrier systems) can shift formulation economics.
  • Capital intensity and integration execution: Manufacturing investments and acquisition integration carry execution risk and can affect returns if utilization or synergies fall short.

📊 Valuation & Market View

Equity markets typically value ingredient and specialty chemical businesses using EV/EBITDA, P/S, and cash-flow-based measures, reflecting expected durability of margins and the quality of earnings through cycles. Drivers that often move valuation include:

  • Organic growth rate and mix: sustained specialty mix improves margin durability and earnings resilience.
  • Gross margin and operating leverage: manufacturing utilization, procurement discipline, and pricing discipline influence profitability.
  • Free cash flow conversion: working capital dynamics and capex intensity can affect how much earnings convert to cash.
  • Quality of growth from acquisitions: returns on integrated capacity and the ability to sustain customer relationships post-transaction.

For IFF specifically, market perception generally reflects confidence in its ability to defend switching-cost advantages, manage input volatility, and maintain specialty-led growth rather than revert to commodity-like behavior.

🔍 Investment Takeaway

IFF’s long-term investment case rests on a defensible technical and relationship moat anchored in customer qualification and switching costs, supported by proprietary formulation know-how and an application-led model. With end-market innovation and regulatory-driven reformulation providing recurring ingredient replacement cycles, IFF is positioned to compound through mix improvement and sustained customer integration—provided it manages input volatility, regulatory requirements, and execution discipline in manufacturing and portfolio strategy.


⚠ AI-generated — informational only. Validate using filings before investing.

```

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for IFF.

zacks.com2026-07-31

International Flavors Set to Report Q2 Earnings: What's in Store?

IFF heads into Q2 earnings release with volume growth and productivity gains in focus as investors weigh cost pressures and mixed segment performance.

businesswire.com2026-07-28

IFF Declares Dividend for Third Quarter 2026

NEW YORK--(BUSINESS WIRE)---- $IFF--IFF (NYSE: IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on October 9, 2026 to shareholders of record as of September 18, 2026. Welcome to IFF At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, and health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—advancing w.

zacks.com2026-07-28

International Flavors (IFF) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

International Flavors (IFF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

defenseworld.net2026-07-28

Dimensional Fund Advisors LP Grows Position in International Flavors & Fragrances Inc. $IFF

Dimensional Fund Advisors LP increased its holdings in International Flavors and Fragrances Inc. (NYSE: IFF) by 8.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,809,090 shares of the specialty chemicals company's stock after acquiring an additional 147,896 shares during the

defenseworld.net2026-07-22

California Public Employees Retirement System Purchases 12,614 Shares of International Flavors & Fragrances Inc. $IFF

California Public Employees Retirement System raised its position in shares of International Flavors and Fragrances Inc. (NYSE: IFF) by 3.3% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 392,499 shares of the specialty chemicals company's stock after acquiring an

prnewswire.com2026-07-20

SuanNutra, a Carbyne Equity Partners Portfolio Company, Expands Product Portfolio with Specialty Natural Ingredients Businesses from IFF

MADRID, July 20, 2026 /PRNewswire/ -- SuanNutra, a global provider of science-backed branded and functional ingredients, and Carbyne Equity Partners today announced that SuanNutra has signed an agreement to acquire a portfolio of specialty natural ingredients businesses from IFF (NYSE: IFF). The businesses will merge with SuanNutra's existing operations to create an enlarged global group in science-backed natural ingredients.

businesswire.com2026-07-20

IFF Announces Agreement to Sell Its Portfolio of Botanical Extracts, Vitamins & Minerals and Food Enhancement Activities to SuanNutra, a Portfolio Company of Carbyne Equity Partners.

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) — a global leader in flavors, fragrances, and health and biosciences — today announced that it has entered into an agreement with SuanNutra, a Carbyne Equity Partners portfolio company and global provider of science-backed branded and functional ingredients, to sell its portfolio of botanical extracts, vitamins and minerals, and food enhancement activities, including its range of natural colors and antioxidants and certain localized flavor activities i.

businesswire.com2026-07-09

IFF to Release Second Quarter 2026 Results on August 4, 2026

NEW YORK--(BUSINESS WIRE)---- $IFF--IFF (NYSE: IFF) today announced that it will release its second quarter 2026 earnings results following the market close on Tuesday, August 4, 2026. The management team will host a live webcast on Wednesday, August 5, 2026, at 9:00 a.m. ET to discuss results and outlook with the investor community. Investors may access the live webcast and accompanying slide presentation on the company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded.

zacks.com2026-07-02

IFF Advances Pro-Fragrance Innovation With SENSORA Launch

International Flavors launches patent-pending SENSORA, a pro-fragrance technology that extends scent for up to 20 days and debuts with Floral Fusion detergents.

businesswire.com2026-06-30

IFF Launches SENSORA™, an Innovative Pro-Fragrance Technology Platform

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) — a global leader in flavors, fragrances, food ingredients and health and biosciences — today announced the launch of SENSORA™, its advanced patent-pending pro-fragrance technology designed to transform how scent is experienced across home, fabric and personal care applications. Developed to meet the rising demand for a longer-lasting and more sophisticated scent experience, SENSORA™ delivers an evolving olfactive profile with sustained release, extend.

gurufocus.com2026-06-16

IFF and ISIPCA Mark 10 Years of Joint Scent Design and Creation Master's-Level Program

[url="]IFF[/url] — a global leader in flavors, fragrances, food ingredients and health and biosciences — celebrates the 10th anniversary of its industry-lead

businesswire.com2026-06-16

IFF and ISIPCA Mark 10 Years of Joint Scent Design and Creation Master's-Level Program

VERSAILLES, France--(BUSINESS WIRE)--IFF — a global leader in flavors, fragrances, food ingredients and health & biosciences — celebrates the 10th anniversary of its industry-leading accredited master's-level program for scent design and creation, developed in partnership with ISIPCA, the world-renowned school for careers in perfume, cosmetics and food flavors. Since its launch in 2016, the IFF ISIPCA program has trained more than 180 professionals from 40 countries, with 130 graduates to d.

businesswire.com2026-06-09

IFF's 2025 Do More Good Report Highlights Progress in Nature-Based Innovation

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) — a global leader in flavors, fragrances, food ingredients and health & biosciences — released its 2025 Do More Good Report, highlighting the company's commitment to creating better products and experiences for people and the planet. IFF's increasingly nature-based portfolio underscores the central role of sustainability and positions its innovation at the intersection of biology and chemistry. Through continued investment in R&D, expanded glob.

zacks.com2026-06-04

International Flavors (IFF) Down 11.3% Since Last Earnings Report: Can It Rebound?

International Flavors (IFF) reported earnings 30 days ago. What's next for the stock?

zacks.com2026-06-01

IFF to Optimize Portfolio With Its Food Ingredients Business Sale

International Flavors sells its Food Ingredients unit as part of a portfolio overhaul, aiming to cut debt and focus on higher-growth, innovation-led segments.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"IFF reported Q1 2026 revenue of $2.741B and net income of $169M (EPS $0.66). QoQ, revenue rose to $2.741B from $2.589B (+5.8%), and net income surged from $18M to $169M (+838%). YoY, revenue declined slightly from $2.843B to $2.741B (-3.6%), while net income improved sharply from -$1.018B to +$169M (a turnaround of +$1.187B). Profitability improved meaningfully on both an absolute and margin basis versus both Q4 and the prior year: gross margin increased to 37.1% from 29.2% (QoQ, +7.9pp) and was roughly flat YoY (36.4% vs. 36.4%). Operating margin recovered to 10.0% from 6.4% (QoQ, +3.6pp) and versus the prior-year Q1 loss (from -31.8% to +10.0%). Net margin expanded to 6.2% from 0.7% QoQ (+5.3pp) and versus -35.8% YoY. Cash flow quality remained solid: operating cash flow was $257M and free cash flow was $92M in Q1 2026, with dividends paid of $102M and modest share repurchases ($35M). Balance sheet leverage eased modestly: total assets slipped to $25.14B from $25.54B (QoQ), while equity stayed stable near $14.15B. Shareholder returns are supported by strong 6-month momentum (+21.2%) and positive 1-year price performance (+6.8%). Analysts have a consensus target of ~$87.75 versus $75.88, implying upside. Total shareholder returns are driven primarily by price appreciation here (dividend yield is low)."

Revenue Growth

Neutral

QoQ revenue increased +5.8% ($2.589B to $2.741B) but YoY was down -3.6% ($2.843B to $2.741B), indicating stabilization/partial rebound rather than broad growth.

Profitability

Strong

Margins materially expanded: gross margin to 37.1% from 29.2% QoQ; operating margin to 10.0% from 6.4% QoQ; net margin to 6.2% from 0.7% QoQ. YoY net income improved from -$1.018B to +$169M.

Cash Flow Quality

Positive

Q1 2026 operating cash flow was $257M and free cash flow $92M. Dividends were $102M with additional buybacks of $35M; coverage improved versus the prior-year loss quarter but remains dividend-heavy given payout metrics.

Leverage & Balance Sheet

Neutral

Assets declined QoQ ($25.54B to $25.14B). Equity was stable (~$14.15B). Net debt eased modestly to $5.78B from $6.06B, suggesting improving resilience.

Shareholder Returns

Positive

Price momentum is positive but not >20% over 1 year (+6.8%). 6-month performance is strong (+21.2%), supporting sentiment. Dividend yield is low (about 0.6%). Buybacks were modest in the quarter.

Analyst Sentiment & Valuation

Good

Consensus target ($87.75) is above the current price ($75.88), implying ~15.7% upside. Targets range from 75 to 97, indicating constructive but not uniform expectations.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

IFF delivered a strong Q1 2026 start: revenue >$2.7B (+3% sales) and adjusted operating EBITDA of $568M (+8%), producing a 20.7% margin and a 110 bps currency-neutral improvement—the best since Q2 2022. Gains were volume-led with productivity benefits across Taste, Food Ingredients (volume ~5% highest in years), and Health & Biosciences. Capital discipline and cash generation improved as free cash flow was $92M (+$144M YoY), with net leverage at 2.5x and gross debt down >$3B YoY. The near-term watch item is guidance phasing: Q2 EBITDA is expected to be below Q1 due to energy/logistics inflation not yet fully recovered through surcharges, plus Middle East-driven Fine Fragrance softness and supply-chain packaging delays. Management reiterated FY 2026 ranges ($10.5B–$10.8B sales; $2.05B–$2.15B EBITDA), noting pricing actions should ease pressure in the back half.

AI IconGrowth Catalysts

  • Volume-led growth across all segments (Health & Biosciences mid-single digits; Taste/Food Ingredients/Scent low single digits)
  • Productivity gains contributing to margin expansion (currency-neutral adjusted EBITDA margin up 110 bps)
  • Health & Biosciences production expansion in Latin America: Arroyito site (Argentina) fermentation-based enzyme production; Brazil household care application laboratory at IFF Innovation Center
  • Food Ingredients volume up ~5% (highest in several years) supported by inclusion and systems growth

Business Development

  • Divestiture completed: sold commodity soy crush, concentrates and lecithin business to Bunge for $110 million (closed March 2)
  • Food Ingredients sale process: multiple potential buyers in second-round due diligence; update expected by Q2 earnings call
  • Regional production/innovation additions: Arroyito (Argentina) and household care application lab in Brazil (IFF Innovation Center)
  • Alpha Bio mentioned as an example of venture capital allocation focus

AI IconFinancial Highlights

  • Revenue: >$2.7B; 3% sales growth on comparable currency-neutral basis
  • Adjusted operating EBITDA: $568M, up 8% YoY driven by volume and productivity gains
  • Adjusted operating EBITDA margin: 20.7% (up 110 bps currency-neutral), highest since Q2 2022
  • Segment highlights: Taste revenue +2% to $656M; adjusted operating EBITDA +18% to $153M
  • Food Ingredients: revenue +3% to $839M; volume growth ~5%; adjusted operating EBITDA +12% to $114M
  • Health & Biosciences: revenue +5% to $595M; adjusted operating EBITDA +7% to $153M
  • Scent: revenue +1% to $651M; adjusted operating EBITDA -2% to $148M due to unfavorable price-to-input costs and weak commodity Fragrance Ingredients

AI IconCapital Funding

  • Dividends returned $102M in Q1
  • Dilution plus share repurchase program returned additional $35M in Q1
  • Cash and cash equivalents: $562M at March 31
  • Gross debt: $5.85B (down >$3B vs prior-year period)
  • Net debt / credit-adjusted EBITDA: 2.5x (slightly below last quarter)
  • Trailing 12-month credit-adjusted EBITDA: ~ $2.1B
  • CapEx: $165M year-to-date (~6% of sales)
  • Free cash flow: $92M (up $144M YoY)

AI IconStrategy & Ops

  • Working capital focus remains a key 2026 priority; operating cash flow up $130M YoY to $257M
  • Portfolio simplification continues; Food Ingredients divestiture process progressing with strong interest
  • Inflation mitigation approach: customer pricing surcharges for logistics/energy then raw materials inflation
  • Scent commodity ingredients strategy shift: deemphasizing external commodity Fragrance Ingredients sales while strengthening specialty emphasis

AI IconMarket Outlook

  • Full-year 2026 guidance reaffirmed: Sales $10.5B–$10.8B (1%–4% growth)
  • Full-year adjusted operating EBITDA guidance: $2.05B–$2.15B (3%–8% growth with margin expansion)
  • FX: expected ~1 percentage point positive impact on full-year sales growth; minimal impact on adjusted EBITDA growth
  • Guidance shape change vs prior: soy crush/concentrates/lecithin divestiture included only 2 months of results; closure March 2 (about 1 month ahead of April 1 embedded in original guidance)
  • Q2 2026 expectation: EBITDA lower than Q1 ($568M) due to moderate growth, price-to-input unfavorability (energy/logistics charges rising; surcharges not fully implemented yet), and Fine Fragrance softness/mix from Middle East

AI IconRisks & Headwinds

  • Middle East conflict expected to increase inflationary pressures over 2026; profitability adversely impacted in Q2 as pricing actions lag
  • Scent exposure: Fine Fragrance volume in Middle East impacted in Q2 by slower market demand and customer packaging supply chain challenges
  • Scent Fragrance Ingredients: commodity portion challenged by Indian and Chinese producers; unfavorable price-to-input costs in Q1
  • Price-to-input cost mismatch risk in near term: energy/logistics inflation rising before surcharges fully implemented
  • Consumer demand risk scenario: higher-end EBITDA/sales require end-market demand improvement; lower-end assumes continued weakness

Q&A: Analyst Interest

  • Outperformance drivers & prebuy risk: Management attributed Q1 upside to volume-led growth across all segments and continued productivity execution. They stated they saw no indication of significant customer prebuying or out-of-pattern ordering, while acknowledging they do not know each customer’s specific order motives.
  • Food Ingredients sale process timeline: Management said the process is disciplined and progressing well, with several potential buyers in second-round due diligence and feedback “very positive.” They highlighted strong business performance (double-digit EBITDA growth in 2025 and Q1 2026) and guided for an update by the second-quarter earnings call.
  • Inflation/pricing assumptions and magnitude: Management discussed inflation dimensionalization via Brent crude as an indicator, with near-term energy/logistics costs already showing double-digit increases and raw materials expected to shift later in the year. They emphasized customer surcharge implementation underway, and stated historical practice typically offsets inflation via pricing over a 12–18 month cycle.

Sentiment: MIXED

Note: This summary was synthesized by AI from the IFF Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for IFF.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (IFF)

© 2026 Stock Market Info — International Flavors & Fragrances Inc. (IFF) Financial Profile